← Back to guidelines
Pharmacology208 papers

Rotavirus food poisoning

Last edited: 4/14/2026

Overview

Rotavirus primarily affects young children, causing severe gastroenteritis characterized by diarrhea, vomiting, and dehydration. It is highly contagious and a significant global health issue, particularly in underdeveloped countries 14.

Diagnosis

  • Clinical symptoms include acute watery diarrhea, vomiting, fever, and abdominal pain.
  • Stool samples can be tested for rotavirus antigen using enzyme immunoassays 116.
  • Electron microscopy may be necessary for initial investigation of outbreaks, especially in elderly populations 1617.
  • Management

  • Oral rehydration therapy (ORT) is crucial to prevent and treat dehydration 9.
  • Zinc supplementation can be considered to reduce the duration and severity of diarrhea 9.
  • No specific antiviral treatments are available; supportive care is the mainstay 9.
  • Special Populations

  • Pediatrics: Vaccination is highly recommended to prevent severe rotavirus infections 1278.
  • Elderly: While less common, rotavirus outbreaks can occur in geriatric settings; enhanced hygiene measures are advised 1617.
  • Comorbidities: No specific management adjustments noted in the abstracts; supportive care remains key 9.
  • Key Recommendations

  • Implement rotavirus vaccination programs for infants to reduce severe disease burden (Evidence: Strong 1278).
  • Prioritize oral rehydration therapy and zinc supplementation in pediatric patients to manage dehydration and shorten illness duration (Evidence: Moderate 9).
  • Monitor for adverse events following rotavirus vaccination, particularly intussusception, especially in the first few months post-vaccination (Evidence: Moderate 2811).
  • Enhance infection control measures in geriatric facilities to prevent outbreaks among elderly populations (Evidence: Expert opinion 1617).
  • References

    1 Aram C, Karami L, Ranjbar MM. Development of a candidate mRNA vaccine based on Multi-Peptide targeting VP4 of rotavirus A: an immunoinformatics and molecular dynamics approach. Scientific reports 2025. link 2 Jeong NY, Cho H, Kim HJ, Choi NK. A broad assessment of rotavirus vaccine safety in infants in Korea: Insights from a data-driven signal detection approach. Human vaccines & immunotherapeutics 2025. link 3 Amin AB, Cates JE, Liu Z, Wu J, Ali I, Rodriguez A et al.. Rotavirus Genotypes in the Postvaccine Era: A Systematic Review and Meta-analysis of Global, Regional, and Temporal Trends by Rotavirus Vaccine Introduction. The Journal of infectious diseases 2024. link 4 Sharma AD, Grewal RK, Gorle S, Cuspoca AF, Kaushik V, Rajjak Shaikh A et al.. T cell epitope based vaccine design while targeting outer capsid proteins of rotavirus strains infecting neonates: an immunoinformatics approach. Journal of biomolecular structure & dynamics 2024. link 5 Almohaimeed HM, Abdulfattah AM, Alsulaimani F, Alshammary A, Almohaini MO, Almehiny KA et al.. Prediction of promiscuous multiepitope-based peptide vaccine against RdRp of rotavirus using immunoinformatics studies. Revista do Instituto de Medicina Tropical de Sao Paulo 2024. link 6 Sharif N, Sharif N, Khan A, Azpíroz ID, Diaz RM, Díez IT et al.. Prevalence and genetic diversity of rotavirus in Bangladesh during pre-vaccination period, 1973-2023: a meta-analysis. Frontiers in immunology 2023. link 7 Stenmarker M, Oldin C, Golsäter M, Blennow M, Enskär K, Nilsson MP et al.. Child health professionals' experiences of the introduction and successful implementation of rotavirus vaccination in Sweden. Acta paediatrica (Oslo, Norway : 1992) 2021. link 8 Haber P, Tate J, Marquez PL, Moro PL, Parashar U. Safety profile of rotavirus vaccines among individuals aged ≥8 months of age, United States, vaccine adverse event reporting system (VAERS), 2006-2019. Vaccine 2021. link 9 Price S. Talk to Patients About: Rotavirus. Texas medicine 2019. link 10 . Postmarketing monitoring of intussusception after RotaTeq vaccination--United States, February 1, 2006-February 15, 2007. MMWR. Morbidity and mortality weekly report 2007. link 11 Haber P, Chen RT, Zanardi LR, Mootrey GT, English R, Braun MM. An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?. Pediatrics 2004. link 12 . Suspension of rotavirus vaccine after reports of intussusception--United States, 1999. MMWR. Morbidity and mortality weekly report 2004. link 13 Geier DA, Geier MR. Gastrointestinal reactions and rotavirus vaccination based upon analysis of the Vaccine Adverse Events Reporting System (VAERS) database for 1999. A model for the calculation of the incidence rates and statistical significance of adverse events following immunization. Hepato-gastroenterology 2004. link 14 McPhillips HA, Davis RL, Marcuse EK, Taylor JA. The rotavirus vaccine's withdrawal and physicians' trust in vaccine safety mechanisms. Archives of pediatrics & adolescent medicine 2001. link 15 Groene WS, Shaw RD. Psoralen preparation of antigenically intact noninfectious rotavirus particles. Journal of virological methods 1992. link90172-a) 16 Abbas AM, Denton MD. An outbreak of rotavirus infection in a geriatric hospital. The Journal of hospital infection 1987. link90099-5) 17 Cubitt WD, Holzel H. An outbreak of rotavirus infection in a long-stay ward of a geriatric hospital. Journal of clinical pathology 1980. link

    Original source

    1. [1]
    2. [2]
    3. [3]
    4. [4]
      T cell epitope based vaccine design while targeting outer capsid proteins of rotavirus strains infecting neonates: an immunoinformatics approach.Sharma AD, Grewal RK, Gorle S, Cuspoca AF, Kaushik V, Rajjak Shaikh A et al. Journal of biomolecular structure & dynamics (2024)
    5. [5]
      Prediction of promiscuous multiepitope-based peptide vaccine against RdRp of rotavirus using immunoinformatics studies.Almohaimeed HM, Abdulfattah AM, Alsulaimani F, Alshammary A, Almohaini MO, Almehiny KA et al. Revista do Instituto de Medicina Tropical de Sao Paulo (2024)
    6. [6]
      Prevalence and genetic diversity of rotavirus in Bangladesh during pre-vaccination period, 1973-2023: a meta-analysis.Sharif N, Sharif N, Khan A, Azpíroz ID, Diaz RM, Díez IT et al. Frontiers in immunology (2023)
    7. [7]
      Child health professionals' experiences of the introduction and successful implementation of rotavirus vaccination in Sweden.Stenmarker M, Oldin C, Golsäter M, Blennow M, Enskär K, Nilsson MP et al. Acta paediatrica (Oslo, Norway : 1992) (2021)
    8. [8]
    9. [9]
      Talk to Patients About: Rotavirus.Price S Texas medicine (2019)
    10. [10]
    11. [11]
      An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?Haber P, Chen RT, Zanardi LR, Mootrey GT, English R, Braun MM Pediatrics (2004)
    12. [12]
    13. [13]
    14. [14]
      The rotavirus vaccine's withdrawal and physicians' trust in vaccine safety mechanisms.McPhillips HA, Davis RL, Marcuse EK, Taylor JA Archives of pediatrics & adolescent medicine (2001)
    15. [15]
      Psoralen preparation of antigenically intact noninfectious rotavirus particles.Groene WS, Shaw RD Journal of virological methods (1992)
    16. [16]
      An outbreak of rotavirus infection in a geriatric hospital.Abbas AM, Denton MD The Journal of hospital infection (1987)
    17. [17]
      An outbreak of rotavirus infection in a long-stay ward of a geriatric hospital.Cubitt WD, Holzel H Journal of clinical pathology (1980)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG